Status:
COMPLETED
Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Cataracts
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
This study will test the effectiveness of an intraocular lens treated with heparin in reducing or preventing inflammation after cataract surgery in patients with uveitis. Patients with uveitis (infla...
Detailed Description
The purpose of this project is to evaluate the ability of a heparin-surface modified intraocular lens to reduce the incidence and severity of post-operative inflammation in patients with uveitis under...
Eligibility Criteria
Follow-up Only.
Key Trial Info
Start Date :
April 1 1992
Trial Type :
INTERVENTIONAL
End Date :
February 1 2001
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00001311
Start Date
April 1 1992
End Date
February 1 2001
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Eye Institute (NEI)
Bethesda, Maryland, United States, 20892